Pharmaleads to present at BioTrinity 2018 in Lontodon
Paris, France, [19 April 2018] – Pharmaleads, an emerging pharmaceutical company developing innovative non-opiate products for the management of acute and chronic severe pain, will present at BioTrinity 2018 in Lontodon on Tuesday, April 24th at 3.35pm. Michel Wurm, VP Medical Affairs, will introduce Pharmaleads and its innovative compounds, PL265 and PL37, which protect enkephalins, […] Read full post »
Published on April 19, 2018